BAUDAX BIO INC COM PAR $0.01

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch BXRXQ and buy or sell other stocks, ETFs, and their options commission-free!

About BXRXQ

Baudax Bio, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of products for acute care settings. 

CEO
Gerri A. Henwood
CEOGerri A. Henwood
Employees
9
Employees9
Headquarters
Malvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded
2015
Founded2015
Employees
9
Employees9

BXRXQ Key Statistics

Market cap
4.36K
Market cap4.36K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
7.00
Average volume7.00
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.0001
52 Week high$0.0001
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

The current BAUDAX BIO INC COM PAR $0.01(BXRXQ) stock price is $0.00, with a market capitalization of 4.36K.

BAUDAX BIO INC COM PAR $0.01(BXRXQ) stock opened on 2026-05-05 at —. The price climbed to — and dipped to —.

BAUDAX BIO INC COM PAR $0.01(BXRXQ) shares are trading with a volume of 0, against a daily average of 7.

During the past year, BAUDAX BIO INC COM PAR $0.01(BXRXQ) stock moved between $0.00 at its lowest and $0.00 at its peak.

During the past year, BAUDAX BIO INC COM PAR $0.01(BXRXQ) stock moved between $0.00 at its lowest and $0.00 at its peak.

People also own

Based on the portfolios of people who own BXRXQ. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.